Angioblast Systems, Inc.

Angioblast Systems, Inc.
275 Madison Ave 4th floor
New York
United States
www.angioblast.com
Financial year end:
December
Major products & services
Angioblast Systems, Inc. is a US based biotechnology company. The company's key products include the following,
Commercialization of Therapeutic Products
Adult stem cells
Protein Therapeutics
Gene silencing,
Small molecule peptides and antibodies
Cytokines and antigen-receptor inhibitors
DNAzymes
MPC products
Buy the Full Version
The following reports are available on Angioblast Systems, Inc.:
Angioblast Systems, Inc. - Medical Equipment Product Pipeline Analysis
Price:$750.00
Information panel
News alerts
Sign-up for NewsAlerts on Angioblast Systems, Inc.. So that whenever news breaks on this company you are amongst the first to know.
Please enter a valid email address

